Literature DB >> 2318886

Regulation of in vitro transcription by progesterone receptor. Characterization and kinetic studies.

M K Bagchi1, S Y Tsai, N L Weigel, M J Tsai, B W O'Malley.   

Abstract

We have devised an in vitro assay system to study the transcriptional activity of native chicken progesterone receptor (cPR). Purified cPR added to cell-free extracts from HeLa cell nuclei stimulates accurate transcription from a promoter driven by two progesterone response elements. The transcriptional enhancement is entirely progesterone response element dependent and promoter specific. We have defined the appropriate conditions of template, nuclear extract, salt, and magnesium ion requirements for efficient transcriptional enhancement by cPR. Under optimized conditions, a synthesis rate of one transcript/20 promoters is achieved in the presence of saturating amounts of cPR. Kinetic studies suggest that the progesterone receptor can form a functional preinitiation complex with RNA polymerase II and other transcription factors present in unfractionated HeLa nuclear extract. Following formation of this complex, transcription can commence rapidly upon addition of nucleotides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318886

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Mechanism by which the IFN-beta enhanceosome activates transcription.

Authors:  J Yie; K Senger; D Thanos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  Progesterone enhances target gene transcription by receptor free of heat shock proteins hsp90, hsp56, and hsp70.

Authors:  M K Bagchi; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

3.  Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.

Authors:  Hana Kostrhunova; Jaroslav Malina; Amanda J Pickard; Jana Stepankova; Marie Vojtiskova; Jana Kasparkova; Tereza Muchova; Matthew L Rohlfing; Ulrich Bierbach; Viktor Brabec
Journal:  Mol Pharm       Date:  2011-08-17       Impact factor: 4.939

4.  Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.

Authors:  G X Tong; M Jeyakumar; M R Tanen; M K Bagchi
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

5.  Stimulation of transcription in vitro from a liver-specific promoter by human glucocorticoid receptor (hGRalpha).

Authors:  G Schweizer-Groyer; F Cadepond; N Jibard; E Neau; I Segard-Maurel; E E Baulieu; A Groyer
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

6.  E1A-mediated repression of progesterone receptor-dependent transactivation involves inhibition of the assembly of a multisubunit coactivation complex.

Authors:  Y Xu; L Klein-Hitpass; M K Bagchi
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

7.  Mechanism of estrogen receptor-dependent transcription in a cell-free system.

Authors:  J F Elliston; S E Fawell; L Klein-Hitpass; S Y Tsai; M J Tsai; M G Parker; B W O'Malley
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

8.  Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin.

Authors:  Z Liu; J Wong; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

9.  Ligand and DNA-dependent phosphorylation of human progesterone receptor in vitro.

Authors:  M K Bagchi; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 10.  The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease.

Authors:  A Sasha Tait; Cherie L Butts; Esther M Sternberg
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.